Huapont Life Sciences Co Ltd (002004) — Cash Flow Reinvestment Rate
Huapont Life Sciences Co Ltd (002004) has a Cash Flow Reinvestment Rate of 0.25x as of September 2025, reinvesting CN¥160.05 Million (capex CN¥160.05 Million ) from operating cash flow of CN¥635.17 Million. Check Huapont Life Sciences Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Huapont Life Sciences Co Ltd Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for Huapont Life Sciences Co Ltd across 24 annual periods. Explore 002004 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Huapont Life Sciences Co Ltd (2002–2025)
Year-by-year capital reinvestment analysis for Huapont Life Sciences Co Ltd. For live market cap and broader valuation context, see Huapont Life Sciences Co Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.63x | CN¥1.32 Billion | CN¥2.10 Billion | CN¥638.28 Million | ▼ -15.1% |
| 2024 | 0.74x | CN¥1.20 Billion | CN¥1.63 Billion | CN¥956.27 Million | ▼ -21.3% |
| 2023 | 0.94x | CN¥1.50 Billion | CN¥1.59 Billion | CN¥1.28 Billion | ▲ +32.0% |
| 2022 | 0.71x | CN¥1.72 Billion | CN¥2.41 Billion | CN¥1.13 Billion | ▼ -41.9% |
| 2021 | 1.23x | CN¥1.56 Billion | CN¥1.27 Billion | CN¥1.26 Billion | ▲ +51.9% |
| 2020 | 0.81x | CN¥1.92 Billion | CN¥2.37 Billion | CN¥1.23 Billion | ▲ +1.2% |
| 2019 | 0.80x | CN¥1.66 Billion | CN¥2.08 Billion | CN¥1.43 Billion | ▲ +1.1% |
| 2018 | 0.79x | CN¥1.51 Billion | CN¥1.91 Billion | CN¥1.10 Billion | ▼ -53.9% |
| 2017 | 1.71x | CN¥1.01 Billion | CN¥591.40 Million | CN¥972.67 Million | ▼ -76.2% |
| 2016 | 7.18x | CN¥3.68 Billion | CN¥511.90 Million | CN¥651.24 Million | ▲ +189.1% |
| 2015 | 2.48x | CN¥850.93 Million | CN¥342.45 Million | CN¥831.76 Million | ▲ +93.5% |
| 2014 | 1.28x | CN¥585.54 Million | CN¥455.96 Million | CN¥585.54 Million | ▲ +18.2% |
| 2013 | 1.09x | CN¥379.81 Million | CN¥349.51 Million | CN¥379.81 Million | ▼ -11.1% |
| 2012 | 1.22x | CN¥315.21 Million | CN¥257.75 Million | CN¥315.21 Million | ▲ +72.7% |
| 2011 | 0.71x | CN¥95.77 Million | CN¥135.23 Million | CN¥95.77 Million | ▼ -0.6% |
| 2010 | 0.71x | CN¥56.87 Million | CN¥79.84 Million | CN¥56.87 Million | ▲ +19.8% |
| 2009 | 0.59x | CN¥73.46 Million | CN¥123.53 Million | CN¥73.46 Million | ▼ -26.9% |
| 2008 | 0.81x | CN¥92.49 Million | CN¥113.76 Million | CN¥92.49 Million | ▼ -48.1% |
| 2007 | 1.57x | CN¥124.02 Million | CN¥79.21 Million | CN¥124.02 Million | ▲ +116.7% |
| 2006 | 0.72x | CN¥47.76 Million | CN¥66.10 Million | CN¥47.76 Million | ▼ -28.9% |
| 2005 | 1.02x | CN¥44.42 Million | CN¥43.69 Million | CN¥44.42 Million | ▲ +167.6% |
| 2004 | 0.38x | CN¥26.83 Million | CN¥70.60 Million | CN¥26.83 Million | ▼ -30.1% |
| 2003 | 0.54x | CN¥30.82 Million | CN¥56.68 Million | CN¥30.82 Million | ▼ -62.0% |
| 2002 | 1.43x | CN¥52.71 Million | CN¥36.88 Million | CN¥52.71 Million | — |